Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length Plasmodium falciparum Circumsporozoite Protein

類似資料

• Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
  著者:: Webster, Daniel P., 等
  出版事項: (2005)
• A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge
  著者:: Dunachie, S. J., 等
  出版事項: (2006)
• Invariant Vα14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Specific Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8(+) T Cells in the Liver after Poxvirus Vaccination of Mice
  著者:: Korten, Simone, 等
  出版事項: (2005)
• Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization
  著者:: Naito, Toshio, 等
  出版事項: (2007)
• Oncolytic properties of non-vaccinia poxviruses
  著者:: Ricordel, Marine, 等
  出版事項: (2018)